At3g57050 Antibody

What is At3g57050 and why is it significant for plant researchers?

At3g57050 encodes cystathionine beta-lyase (CBL), a chloroplastic enzyme in Arabidopsis thaliana that catalyzes the reaction: L-cystathionine + H₂O → L-homocysteine + NH₃ + pyruvate . This enzyme plays a crucial role in the methionine biosynthetic pathway, functioning as the second enzyme in this critical metabolic process . CBL is particularly important for understanding sulfur amino acid metabolism in plants, which influences numerous physiological processes including growth, development, and stress responses. Researchers focusing on plant metabolism, nutritional biology, or stress physiology will find At3g57050 antibodies valuable for tracking this key enzyme's expression and localization.

What are the available types of At3g57050 antibodies?

The primary type available for At3g57050 research is polyclonal antibody raised in rabbits . These antibodies are typically generated using recombinant protein strategies, including:

• Antibodies raised against His-tagged, partial recombinant cystathionine beta-lyase from Arabidopsis thaliana mature chloroplast

• Some antibodies target specific epitopes, such as terminal peptide sequences

• Full-length recombinant protein antibodies (positions 70-464aa)

These polyclonal preparations recognize cystathionine beta-lyase from Arabidopsis thaliana specifically, with documented applications in Western blotting (WB) .

What downstream applications are At3g57050 antibodies optimized for?

At3g57050 antibodies are primarily optimized for Western blotting applications . They have been used successfully in several published studies examining cystathionine beta-lyase expression and function in plant tissues . While Western blotting is the primary validated application, researchers have also adapted these antibodies for:

• Immunohistochemistry to examine tissue localization

• Protein-protein interaction studies

• Tracking expression changes under various environmental conditions

• Validation of knockout or overexpression lines

How should researchers validate the specificity of At3g57050 antibodies?

Validation of At3g57050 antibodies requires multiple complementary approaches:

• Genetic validation: Compare antibody reactivity between wild-type Arabidopsis and T-DNA insertion mutants with disrupted At3g57050 expression (such as those from SALK or GABI-Kat collections)

• Recombinant protein control: Include purified recombinant At3g57050 protein as a positive control (commercial recombinant proteins have ≥85-90% purity as determined by SDS-PAGE)

• Peptide competition assay: Pre-incubate the antibody with excess immunizing peptide/protein to confirm binding specificity

• Cross-reactivity assessment: Test antibody recognition in related plant species to determine specificity boundaries

• Correlation with transcript analysis: Compare protein detection patterns with mRNA expression data obtained through Northern blotting or RT-PCR

What are the optimal sample preparation methods for At3g57050 antibody-based assays?

For optimal results with At3g57050 antibodies, sample preparation should include:

• Tissue selection: Focus on tissues with known CBL expression, particularly chloroplast-containing tissues where the enzyme is primarily localized

• Extraction buffer composition:

  • Use buffer containing 20 mM Tris-HCl (pH 8.0) as a starting point

  • Include protease inhibitors to prevent degradation

  • For membrane-associated fraction analysis, consider detergent optimization

• Fractionation considerations: Since CBL is chloroplastic, researchers may need to perform organelle isolation for enrichment

• Protein quantification: Standardize total protein load using Bradford or BCA assays before immunoblotting

• Denaturation conditions: Standard SDS-PAGE sample preparation with heat denaturation (95°C for 5 minutes) is typically suitable

What controls should be included in experiments using At3g57050 antibodies?

Robust experimental design with At3g57050 antibodies should incorporate:

• Positive controls:

  • Recombinant At3g57050 protein (His-tagged or other purified forms)

  • Tissue samples known to express high levels of CBL

• Negative controls:

  • Preimmune serum at the same concentration as the primary antibody

  • Samples from At3g57050 T-DNA knockout mutants

  • Secondary antibody-only controls to assess non-specific binding

• Loading controls:

  • Housekeeping proteins (e.g., actin, similar to how α-actin was used for normalizing TvCS1 mRNA levels)

  • Total protein staining methods (Ponceau S, Coomassie, etc.)

• Antibody controls:

  • Peptide competition assays to confirm specificity

  • Dilution series to establish optimal working concentration

How can At3g57050 antibodies be used to investigate methionine biosynthesis pathway regulation?

Researchers can employ At3g57050 antibodies to study pathway regulation through:

• Stress response studies: Track CBL protein levels under various stressors (e.g., salinity, as mentioned in result #1) to understand how methionine biosynthesis responds to environmental challenges

• Co-immunoprecipitation: Identify protein interaction partners that may regulate CBL activity or localization

• Correlation with metabolite levels: Combine antibody-based protein quantification with metabolomics analysis of pathway intermediates and products

• Comparative analysis with other pathway enzymes: Use antibodies against multiple enzymes in the pathway, such as methylthioalkylmalate synthase (MAM1), which has correlated expression patterns with BCAT4 (mentioned in result #6)

• Developmental regulation: Track CBL expression across different developmental stages to identify key regulatory transitions

What approaches can resolve contradictory results when using At3g57050 antibodies?

When faced with contradictory results:

• Antibody source verification: Ensure antibody specificity through detailed validation with:

  • Peptide competition assays

  • Multiple antibody lots comparison

  • Testing different commercial sources of anti-At3g57050 antibodies

• Technical troubleshooting:

  • Optimize protein extraction methods for different tissue types

  • Test multiple blocking agents to reduce background

  • Adjust antibody concentration based on signal-to-noise ratio

• Complementary methodologies:

  • Compare protein levels detected by antibodies with mRNA expression data

  • Use recombinant protein expression systems to validate antibody reactivity

  • Employ genetic approaches with T-DNA insertion mutants

• Statistical analysis:

  • Perform multiple biological and technical replicates

  • Use appropriate normalization methods

  • Apply statistical tests to determine significance of observed differences

What methodological approaches allow examination of tissue-specific expression patterns of At3g57050?

To investigate tissue-specific expression:

• Tissue fractionation combined with immunoblotting:

  • Isolate different plant tissues (roots, leaves, flowers, etc.)

  • Prepare standardized protein extracts

  • Compare relative CBL levels via Western blotting

• Immunohistochemistry optimization:

  • Tissue fixation protocols suitable for plant material

  • Antigen retrieval methods to enhance accessibility

  • Signal amplification systems for low-abundance detection

• Combined approaches:

  • Correlate protein detection with tissue-specific transcript data

  • Compare with reporter gene fusion approaches (e.g., GFP-CBL)

• Developmental studies:

  • Track CBL expression across different growth stages

  • Compare expression patterns in response to environmental stimuli

How can researchers troubleshoot non-specific binding issues with At3g57050 antibodies?

When experiencing non-specific binding:

• Optimization of blocking conditions:

  • Test different blocking agents (BSA, non-fat milk, commercial blockers)

  • Increase blocking time and/or concentration

  • Consider including 0.1-0.3% Tween-20 in washing and antibody incubation steps

• Antibody dilution optimization:

  • Perform titration experiments with serial dilutions

  • The optimal dilution should be determined by each end user

  • Start with manufacturer's recommended range and optimize

• Sample preparation improvements:

  • Ensure complete protein denaturation

  • Remove interfering compounds through additional purification steps

  • Consider detergent optimization in extraction buffers

• Cross-reactivity reduction:

  • Pre-absorb antibody with recombinant protein from non-target species

  • Use higher stringency washing conditions

  • Consider affinity purification of polyclonal antibodies

What are the recommended approaches for quantifying At3g57050 expression levels?

For accurate quantification:

• Densitometric analysis:

  • Use calibrated imaging systems with linear detection range

  • Include a standard curve of recombinant At3g57050 protein

  • Normalize to appropriate loading controls (similar to how α-actin was used for normalizing mRNA levels)

• Data normalization strategies:

  • Normalize to housekeeping proteins that remain stable under experimental conditions

  • Consider total protein normalization approaches (Stain-Free technology, Ponceau S)

  • Express results relative to control samples

• Statistical analysis:

  • Perform multiple biological replicates (n≥3)

  • Apply appropriate statistical tests

  • Report results with clear indication of variability (standard deviation or standard error)

• Software tools:

  • Use specialized software for consistent band quantification

  • Apply background subtraction methods

  • Consider advanced image analysis approaches for complex patterns

How can researchers interpret changes in At3g57050 expression in response to environmental stressors?

When analyzing stress responses:

• Experimental design considerations:

  • Include appropriate time course sampling

  • Apply standardized stress conditions

  • Use proper controls for each stress treatment

• Integrated data analysis:

  • Correlate protein changes with physiological parameters

  • Compare with transcript-level changes (similar to methods used for TvCS1 mRNA quantification)

  • Consider parallel analysis of metabolites in the methionine biosynthesis pathway

• Pathway context interpretation:

  • Examine other enzymes in the methionine biosynthesis pathway simultaneously

  • Consider feedback regulation mechanisms

  • Interpret in context of plant adaptive responses

• Cross-validation approaches:

  • Compare antibody-detected changes with reporter gene systems

  • Validate with genetic approaches using overexpression or knockout lines

  • Perform complementation studies to confirm functional significance

How can At3g57050 antibodies be integrated with modern proteomics approaches?

Integration with proteomics includes:

• Immunoprecipitation-mass spectrometry (IP-MS):

  • Use At3g57050 antibodies to pull down protein complexes

  • Identify interaction partners via mass spectrometry

  • Map protein-protein interaction networks relevant to methionine metabolism

• Targeted proteomics:

  • Develop multiple reaction monitoring (MRM) assays for absolute quantification

  • Use antibody-based enrichment prior to MS analysis

  • Enhance detection sensitivity for low-abundance CBL

• Post-translational modification analysis:

  • Combine immunoprecipitation with modification-specific detection methods

  • Identify regulatory modifications affecting CBL activity

  • Map phosphorylation, acetylation, or other modifications under various conditions

What methodological approaches are recommended for studying At3g57050 in non-model plant species?

For non-model species research:

• Cross-reactivity assessment:

  • Test existing antibodies against protein extracts from target species

  • Perform Western blots comparing Arabidopsis and target species samples

  • Use sequence alignment to predict likelihood of cross-reactivity

• Custom antibody development strategies:

  • Identify conserved epitopes across species using sequence alignment

  • Design peptide antigens based on conserved regions

  • Consider generating new antibodies against species-specific sequences

• Validation approaches:

  • Use heterologous expression systems to produce the target species protein

  • Perform complementation studies in Arabidopsis At3g57050 mutants

  • Develop species-specific controls for antibody validation

How can researchers leverage machine learning approaches with At3g57050 antibody data?

Machine learning applications include:

• Pattern recognition in expression data:

  • Train algorithms to identify subtle expression patterns across tissues or conditions

  • Develop predictive models for CBL expression under various stressors

  • Integrate with other -omics datasets for comprehensive pathway analysis

• Image analysis enhancement:

  • Apply deep learning for automated quantification of immunoblot data

  • Develop algorithms for tissue-specific localization in immunohistochemistry

  • Improve signal-to-noise discrimination in complex samples

• Antibody design enhancement:

  • Apply computational approaches similar to MAGE (Monoclonal Antibody GEnerator) described in result #3

  • Use structural prediction to identify optimal epitopes for new antibody development

  • Predict cross-reactivity with related proteins to enhance specificity